Green Fresh Biotechnology Company Limited (HKG:1084)

Market Cap	563.81M -0.8%
Revenue (ttm)	1.19B +9.5%
Net Income	19.93M -36.1%
EPS	0.02 -36.2%
Shares Out	874.12M
PE Ratio	27.95
Forward PE	n/a
Dividend	0.01 (1.86%)
Ex-Dividend Date	Jun 16, 2026

Volume	20,000
Open	0.6300
Previous Close	0.6500
Day's Range	0.6300 - 0.6450
52-Week Range	0.5700 - 0.7900
Beta	-0.24
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 1, 2026

About HKG:1084

Green Fresh Biotechnology Company Limited, an investment holding company, engages in the production of seaweed-based and plant-based hydrocolloid products in the Mainland China, Europe, rest of Asia, South America, North America, Africa, and Oceania. The company operates through five segments: Manufacturing and Sales of Agar-Agar; Manufacturing and Sales of Carrageenan; Manufacturing and Sales of Konjac Products; Manufacturing and Sales of Blended Products; and Others. It offers carrageenan, agar agar, konjac gum, and flour products, as well as...

• Industry: Farm Products
• Sector: Consumer Staples
• Founded: 2001
• Employees: 1,030
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1084

Financial Performance

In 2025, HKG:1084's revenue was 904.69 million, a decrease of -8.55% compared to the previous year's 989.26 million. Earnings were 6.59 million, a decrease of -89.40%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 6, 2026

Data Sources Report a data error